Session II (b): CAR-T and Beyond: Cellular Therapies in Autoimmune Disease

Preconference Moderator(s)

• MM

  Marcela Maus, MD, PhD

  Harvard
  Charlestown, MA, United States

  Disclosure information not submitted.

Presentations:

• 1:15 PM - 1:45 PM Central Time

  Bispecifics vs. CAR-T: How Oncologists Decide Between the Two
  

  Preconference Speaker: Andrew Yee
• 1:45 PM - 2:15 PM Central Time

  Cytokine Modulation: Translational Talk About Toxicities, Learnings from Oncology About Cytokine Pathways, Mechanisms, and Drugs Used
  

  Preconference Speaker: Caroline Diorio, MD (she/her/hers) – Children's Hospital of Philadelphia